HOLLISTON, Mass., Oct. 4 /PRNewswire/ -- VCG & A Inc. (VCG & Associates), a pharmaceutical consulting firm headquartered in Holliston, MA, is pleased to announce the purchase of New Pharmaceutical Strategies, Inc., a Florida corporation. Both companies are leaders in providing business consulting to the pharmaceutical market.
VCG & Associates specializes in working with proprietary pharmaceutical companies and the biotech industry providing strategies and tactics related to commercial product launch activities. VCG & Associates fields one of the largest contract National Account teams in the industry providing manufacturers access to key decision makers in order to help accelerate the selling process to the third party market. New Pharmaceutical Strategies provides consulting services with regard to pharmaceutical product distribution and supply chain management.
Mike Schultz, Chief Operating Officer and Brad Fleahman, President, VCG & Associates call the acquisition a logical progression of expanding VCG & Associates services to the pharmaceutical industry. This acquisition continues to position VCG & Associates as a leader in providing outsourced commercialization services to the pharmaceutical market. “We are excited by the experience, reputation and expertise that NPS adds to our portfolio of services. On a combined basis, we have assisted well over 50 pharmaceutical companies with their launch and reimbursement efforts,” stated Mr. Fleahman. The acquisition will be seamless to current clients, as New Pharmaceutical Strategies will be integrated as a wholly-owned operating unit of VCG & Associates.
John Gaffney, CEO of New Pharmaceutical Strategies, is likewise excited about combining the resources of the two organizations. He indicated that he has worked closely with VCG & Associates on previous projects. Mr. Gaffney stated, “I am excited about this relationship as the synergies of both firms will expand our business model to bring more overall value to current and future clients.” Gaffney, along with Chief Operating Officer Horace Cook, and other New Pharmaceutical Strategies associates will stay on and work under the VCG & Associates umbrella.
Terms of the acquisition are confidential; any further questions should be forwarded to Brad Fleahman at brad.fleahman@vcgassociates.com or John Gaffney at JGGaffney@aol.com. Information on either company is available at their respective websites (www.vcgassociates.com, www.newpharmaceuticalstrategies.com).
VCG & Associates
CONTACT: Brad Fleahman of VCG & Associates,brad.fleahman@vcgassociates.com; or John Gaffney of New PharmaceuticalStrategies, Inc., JGGaffney@aol.com; or VCG & Associates, +1-314-308-2028
